With its walking robot, Andago, Hocoma is now offering new perspectives for patient mobilization, helping to avoid falls among patients and care staff during overground gait training.
"If you think, for example, about a therapist assisting a debilitated person twice his or her weight during gait training, it is obvious that this training is very difficult, requires a lot of skill and still bears risks for both the therapist as well as the patient." states Alberto Esquenazi, chair of the Department of Physical Medicine and Rehabilitation at MossRehab, USA. With the mobile Andago, functional and safe gait training is now possible for both the therapist and the patient in a flexible manner, while requiring far less physical exertion from the therapist.
Hereby, Andago not only provides a safe, but also a permissive environment. Patients that are yet unable to initiate and conduct stepping movements while bearing their whole body weight, can now practice stepping thanks to the body weight support. Further, they can also practice balance and adapting their steps to environmental demands, such as to step over a puddle or up a curb [4].
The Andago® was developed within Hocoma’s globally unique rehab network of medical specialists and patients. The innovative walking robot will be presented in Europe for the first time at the Medica 2015 in Dusseldorf, Germany. Visitors are invited to experience the walking robot for themselves during the live demo.
Further information on Andago® can be found under http://www.hocoma.com/...
- Video Andago-Demo „Coffee to Go": https://youtu.be/7OZGt_jC8kM
- US- Report: http://www.apta.org/...
- Study: http://www.cdc.gov/...
2. Hitcho, E.B., et al., Characteristics and circumstances of falls in a hospital setting: a prospective analysis. J Gen Intern Med, 2004. 19(7): p. 732-9.
3. Forster, A. and J. Young, Incidence and consequences of falls due to stroke: a systematic inquiry. Bmj, 1995. 311(6997): p. 83-6.
4. Harkema, S.J., A.L. Behrman, and H. Barbeau, Locomotor Training: Principles and Practice. First ed. 2011, New York, NY: Oxford University Press.
Legal notes
All Hocoma products are medical devices and must be used in strict adherence to the user manual and only according to the recommendations contained therein; failure to do so may result in personal injury. Please contact Hocoma should you have any questions. For the latest available information about the medical indications, contraindications, side effects and risks associated with the Valedo it is strongly recommended that you regularly consult Hocoma’s website: www.hocoma.com/legalnotes.
Hocoma is currently engaged in the development of the technology described herein. This technology has not been listed with FDA and is currently not available for sale in the USA. Continued development and testing of this device is anticipated to lead to FDA listing and to selling this device for clinical rehabilitation, at which time indications for use and benefits of use will be announced. The information provided herein is indicative of the current research findings from clinical experiments performed with this device and should not be considered to provide approved indications for use or benefits of use. CAUTION: Andago is an investigational device limited by Federal (or United States) law to investigational use.
Failure to consult qualified medical personnel before using the product or any failure to follow either their recommendations or the product instructions can result in personal injury. If at any time after beginning use of the product you experience discomfort or pain, loss of range of movement, or any other problem, stop using the product immediately and consult qualified medical personnel.
This information provides details about medical products, which may not be available in all countries and may not have received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing herein should be construed as a solicitation or promotion of any product or of an indication of any specific use for any product which is not authorized by the laws and regulations of the country where the reader of this information resides.